trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

The body produces antitoxin antibodies as a major defense against exotoxins.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that the body produces antitoxin antibodies as a major defense against exotoxins?

Yes. The body produces and utilizes neutralizing antibodies (antitoxins) as a primary defense mechanism to bind and neutralize bacterial exotoxins.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently supports the concept that neutralizing antibodies serve as a core defense and therapeutic strategy against bacterial exotoxins (e.g., C. difficile toxins, streptolysin O, botulinum neurotoxins).

Evidence for · 3
Isolation of Monoclonal Neutralizing Single-Domain Antibodies Against Clostridioides difficile Toxin B.
2026
Studies like this one demonstrate the isolation and characterization of neutralizing antibodies targeting bacterial exotoxins such as Clostridioides difficile toxin B.
Get citation
IA, A., AS, U., IA, F., AI, T., DV, S., AI, K., ME, K., OL, V., NN, R., EI, E., MS, K., DY, L., MM, B., VV, M., SM, Y., & AL, G. (2026). Isolation of Monoclonal Neutralizing Single-Domain Antibodies Against Clostridioides difficile Toxin B.. doi.org. https://doi.org/10.32607/actanaturae.27874

See more details
More for · 2
A fully human streptolysin O-neutralizing monoclonal antibody improves survival in a murine model of group A streptococcus necrotizing soft tissue infection.
2026
Research on monoclonal antibodies against streptolysin O confirms the protective role of antitoxins in neutralizing key bacterial exotoxins during severe infections.
Get citation
E, P., A, N., S, F., CL, L., ER, M., S, C., M, A., DJ, B., B, S., D, F., DL, S., AE, B., & SE, H. (2026). A fully human streptolysin O-neutralizing monoclonal antibody improves survival in a murine model of group A streptococcus necrotizing soft tissue infection.. doi.org. https://doi.org/10.1128/aac.00575-26

Botulinum neurotoxin: from molecular pathogenesis to emerging countermeasures.
2026
Clinical management of toxin-mediated diseases like botulism relies on antitoxin administration to neutralize circulating bacterial neurotoxins.
Get citation
S, A. (2026). Botulinum neurotoxin: from molecular pathogenesis to emerging countermeasures.. doi.org. https://doi.org/10.1007/s44446-026-00090-2

What does the evidence say?

The retrieved literature consistently supports the concept that neutralizing antibodies serve as a core defense and therapeutic strategy against bacterial exotoxins (e.g., C. difficile toxins, streptolysin O, botulinum neurotoxins).

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work